US Patent Issued to Oculox Technologies on Nov. 3 for "Apparatus for providing retinal therapy, method for tracking a change in retinal cells' functional modification" (Swiss Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,243, issued on Nov. 3, was assigned to Oculox Technologies SA (Muzzano, Switzerland).

"Apparatus for providing retinal therapy, method for tracking a change in retinal cells' functional modification" was invented by Filippo Piffaretti (Giubiasco, Switzerland) and Pascal Faure (Saint Sulpice, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "A confocal scanning laser ophthalmoscope for providing retinal therapy of an eye comprises a first light source configured to emit a treatment beam at a first wavelength to a selected area of the retina, and a retinal functional tracking means. The retinal functional tracking means comprises a broadband s...